BioMarin Pharma (BMRN) Tops Q2 EPS by 12c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. SPY

Go back to BioMarin Pharma (BMRN) Tops Q2 EPS by 12c, Offers Guidance

BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance

August 3, 2022 4:03 PM EDT

VOXZOGO $34 Million Contribution Drives Total Revenues of $534 Million in the Quarter; Total Revenues Grew 13% Year-Over-Year, Excluding KuvanBioMarin Expects that ROCTAVIAN (valoctocogene roxaparvovec) for the Treatment of Severe Hemophilia A Will Be Approved in Europe in the Third Quarter; Re-Submission of Biologics License Application (BLA) in the U.S. Planned for September 2022

Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

Three Months Ended

June 30,

Six Months Ended

June 30,

... More